Literature DB >> 5043223

Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma.

A Di Marco, L Lenaz, A M Casazza, B M Scarpinato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5043223

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  9 in total

1.  Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model.

Authors:  E Zocchi; M Tonetti; C Polvani; L Guida; U Benatti; A De Flora
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

2.  Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.

Authors:  F Formelli; A M Casazza; A Di Marco; A Mariani; C Pollini
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

Authors:  A Rahman; A Fumagalli; B Barbieri; P S Schein; A M Casazza
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Biochemical and biological activity of the anthracycline analog, 4-demethyl-6-O-methyl-doxorubicin.

Authors:  F Zunino; B Barbieri; O Bellini; A M Casazza; C Geroni; F Giuliani; A Ciana; G Manzini; F Quadrifoglio
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

5.  Evaluation of new anthracycline analogs with the human tumor stem cell assay.

Authors:  S E Salmon; R M Liu; A M Casazza
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 6.  The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.

Authors:  A Goldin; J M Venditti; R Geran
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

7.  In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.

Authors:  M Ripamonti; G Pezzoni; E Pesenti; A Pastori; M Farao; A Bargiotti; A Suarato; F Spreafico; M Grandi
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

8.  Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.

Authors:  G Pezzoni; M Grandi; G Biasoli; L Capolongo; D Ballinari; F C Giuliani; B Barbieri; A Pastori; E Pesenti; N Mongelli
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

9.  Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug.

Authors:  G Pratesi; G Savi; G Pezzoni; O Bellini; S Penco; S Tinelli; F Zunino
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.